Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy
Andrew J. Barkmeier, Jeph Herrin, Kavya Swarna, Yihong Deng, Eric C. Polley, Guillermo E. Umpierrez, Rodolfo J. Galindo, Joseph S. Ross, Mindy M. Mickelson, Rozalina G. McCoy
Topics & Concepts
MedicineDiabetic retinopathyPharmacologyGlucagon-like peptide 1 receptorOphthalmologyDipeptidyl peptidase-4Diabetes mellitusReceptorInternal medicineEndocrinologyType 2 diabetesAgonistDiabetes Treatment and ManagementRetinal Diseases and TreatmentsDiabetes Management and Research